MedTrace Logo

Prospective Study for the Evaluation of the Cementless Anatomic Femoral Stem Minimax -Launay

NCT06012656 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2025-09-29

No results posted yet for this study

Summary

This is a post-marketing surveillance on MiniMAX Stem

Conditions

  • Fracture; Femur, Head
  • Primary Osteoarthritis
  • Secondary Osteoarthritis
  • Traumatic Arthritis
  • Rheumatoid Arthritis
  • Congenital Hip Dysplasia
  • Avascular Necrosis

Interventions

DEVICE

MiniMAX

Total or Partial Hip Arthroplasty

Sponsors & Collaborators

  • Medacta International SA

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-02
Primary Completion
2029-01-02
Completion
2031-01-02

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06012656 on ClinicalTrials.gov